C

CareDx
D

CDNA

22.290
USD
-1.05
(-4.50%)
مغلق
حجم التداول
32,990
الربح لكل سهم
-0
العائد الربحي
-
P/E
-8
حجم السوق
1,195,498,985
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACU
    -0.700
    (-1.85%)
    37.100 USD
    B
    BCRX
    -0.17000
    (-1.81%)
    9.20000 USD
    C
    CMP
    0.170
    (1.43%)
    12.050 USD
    C
    CRIS
    -0.03400
    (-1.09%)
    3.07600 USD
    NTR
    NTR
    -0.590
    (-1.11%)
    52.590 USD
    V
    VG
    -1.220
    (-7.36%)
    15.360 USD
    المزيد
الأخبار
المقالات

العنوان: CareDx

القطاع: Healthcare
الصناعة: Diagnostics & Research
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.